Stock-Based Compensation (Details) $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2015USD ($)$ / sharesshares | Dec. 31, 2014USD ($)$ / sharesshares | Dec. 31, 2013USD ($)$ / sharesshares |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | | |
Annual percentage of outstanding shares available for grant, maximum | 5.00% | | |
Cumulative percentage of outstanding shares available for grant in a year, maximum | 10.00% | | |
Salaries, Wages and Officers' Compensation [Abstract] | | | |
Compensation expense, stock-based compensation | $ | $ 2,327 | $ 1,860 | $ 1,411 |
Income tax benefit | $ | $ 694 | $ 549 | $ 348 |
Employee Stock Purchase Plan [Abstract] | | | |
Employee stock purchase plan, service period | 1 year | | |
Employee stock purchase plan, percentage of market price, purchase date | 85.00% | | |
Employee stock purchase, discount from market price, purchase date | 15.00% | | |
Number of employees participating | 1,750 | 1,684 | 1,500 |
Shares purchased during the year | shares | 125,779 | 115,029 | 118,444 |
Weighted-average per share purchase price paid | $ 26.22 | $ 23.07 | $ 20.01 |
Cumulative shares purchased since 1982 | shares | 8,877,034 | 8,751,255 | 8,636,226 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | | | |
Volatility rate | 10.90% | 11.20% | 11.30% |
Risk-free interest rate | 2.10% | 2.60% | 2.10% |
Expected dividend yield | 0.70% | 1.10% | 1.50% |
Expected life of awards (years) | 9 years 3 months 18 days | 9 years 4 months 24 days | 9 years 4 months 24 days |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | | | |
Outstanding, beginning balance | shares | 770,131 | | |
Granted | shares | 148,000 | | |
Exercised | shares | (66,687) | | |
Forfeited | shares | 34,700 | | |
Outstanding, ending balance | shares | 816,744 | 770,131 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Exercisable, ending balance | shares | 416,844 | | |
Outstanding, weighted average exercise price, ending balance | $ 21.58 | $ 19.33 | |
Granted, weighted average exercise price | 30.10 | | |
Exercised, weighted average exercise price | 13.13 | | |
Forfeited, weighted average exercise price | 24.27 | | |
Exercisable, weighted average exercise price | $ 16.68 | | |
Exercisable, weighted average remaining contractual life (years) | 3 years 11 months 16 days | | |
Outstanding, unrecognized compensation cost | $ | $ 1,832 | | |
Outstanding, aggregate intrinsic value | $ | 8,102 | | |
Exercisable, aggregate intrinisic value | $ | 6,178 | | |
Excess tax benefits | $ | 352 | $ 354 | $ 242 |
Employee Stock Purchase Plan [Domain] | | | |
Salaries, Wages and Officers' Compensation [Abstract] | | | |
Compensation expense, stock-based compensation | $ | $ 569 | 463 | 417 |
Employee Stock Purchase Plan [Abstract] | | | |
Employee stock purchase, discount from market price, purchase date | 15.00% | | |
Stock Options [Member] | | | |
Salaries, Wages and Officers' Compensation [Abstract] | | | |
Compensation expense, stock-based compensation | $ | $ 494 | 398 | 234 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | | | |
Vesting period | 10 years | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Outstanding, weighted average remaining contractual life (years) | 6 years 2 months 12 days | | |
Number outstanding | shares | 816,744 | | |
Outstanding options, weighted average exercise price | $ 21.58 | | |
Number exercisable | shares | 416,844 | | |
Exercisable options, weighted average exercise price | $ 16.68 | | |
Stock Options [Member] | $11.25 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 11.25 | | |
Upper range limit | $ 11.25 | | |
Number outstanding | shares | 121,938 | | |
Weighted average remaining contractual life (years) | 4 months 24 days | | |
Outstanding options, weighted average exercise price | $ 11.25 | | |
Number exercisable | shares | 121,938 | | |
Exercisable options, weighted average exercise price | $ 11.25 | | |
Stock Options [Member] | $16.00 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 16 | | |
Upper range limit | $ 16 | | |
Number outstanding | shares | 100,761 | | |
Weighted average remaining contractual life (years) | 3 years 10 months 2 days | | |
Outstanding options, weighted average exercise price | $ 16 | | |
Number exercisable | shares | 100,761 | | |
Exercisable options, weighted average exercise price | $ 16 | | |
Stock Options [Member] | $16.60 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 16.60 | | |
Upper range limit | $ 16.60 | | |
Number outstanding | shares | 96,095 | | |
Weighted average remaining contractual life (years) | 4 years 10 months 2 days | | |
Outstanding options, weighted average exercise price | $ 16.60 | | |
Number exercisable | shares | 96,095 | | |
Exercisable options, weighted average exercise price | $ 16.60 | | |
Stock Options [Member] | $23.20 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 23.20 | | |
Upper range limit | $ 23.20 | | |
Number outstanding | shares | 186,550 | | |
Weighted average remaining contractual life (years) | 7 years 5 months 23 days | | |
Outstanding options, weighted average exercise price | $ 23.20 | | |
Number exercisable | shares | 67,450 | | |
Exercisable options, weighted average exercise price | $ 23.20 | | |
Stock Options [Member] | $16.40 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 26.40 | | |
Upper range limit | $ 26.40 | | |
Number outstanding | shares | 177,400 | | |
Weighted average remaining contractual life (years) | 8 years 6 months | | |
Outstanding options, weighted average exercise price | $ 26.40 | | |
Number exercisable | shares | 30,600 | | |
Exercisable options, weighted average exercise price | $ 26.40 | | |
Stock Options [Member] | $30.10 [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | | | |
Lower range limit | 30.10 | | |
Upper range limit | $ 30.10 | | |
Number outstanding | shares | 134,000 | | |
Weighted average remaining contractual life (years) | 9 years 6 months | | |
Outstanding options, weighted average exercise price | $ 30.10 | | |
Number exercisable | shares | 0 | | |
Exercisable options, weighted average exercise price | $ 30.10 | | |
Stock Appreciation Rights (SARs) [Member] | | | |
Salaries, Wages and Officers' Compensation [Abstract] | | | |
Compensation expense, stock-based compensation | $ | $ 489 | $ 384 | 315 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | | | |
Vesting period | 5 years | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, beginning balance | shares | 303,271 | | |
Granted | shares | 133,550 | | |
Forfeited | shares | 0 | | |
Vested | shares | (106,114) | | |
Unvested, ending balance | shares | 330,707 | 303,271 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, beginning balance | $ 3.84 | | |
Granted, weighted average award date value | 5.78 | | |
Forfeited, weighted average award date value | 0 | | |
Vested, weighted average award date value | 3.76 | | |
Unvested, weighted average award date value, ending balance | $ 4.65 | $ 3.84 | |
Weighted average remaining contractual life (years) | 2 years 10 months 24 days | | |
Unrecognized compensation cost | $ | $ 1,149 | | |
Aggregate intrinsic value, unvested | $ | $ 10,417 | | |
Employee SSARs [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, ending balance | shares | 321,708 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, ending balance | $ 4.71 | | |
Weighted average remaining contractual life (years) | 3 years | | |
Unrecognized compensation cost | $ | $ 1,137 | | |
Aggregate intrinsic value, unvested | $ | $ 10,134 | | |
Nonemployee Director SSARs [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, ending balance | shares | 8,999 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, ending balance | $ 2.23 | | |
Weighted average remaining contractual life (years) | 10 months 24 days | | |
Unrecognized compensation cost | $ | $ 12 | | |
Aggregate intrinsic value, unvested | $ | 283 | | |
Restricted Stock Units (RSUs) [Member] | | | |
Salaries, Wages and Officers' Compensation [Abstract] | | | |
Compensation expense, stock-based compensation | $ | $ 775 | $ 615 | $ 445 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, beginning balance | shares | 117,709 | | |
Granted | shares | 42,152 | | |
Forfeited | shares | 0 | | |
Vested | shares | (17,876) | | |
Unvested, ending balance | shares | 141,985 | 117,709 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, beginning balance | $ 21.14 | | |
Granted, weighted average award date value | 29.14 | | |
Forfeited, weighted average award date value | 0 | | |
Vested, weighted average award date value | 17.44 | | |
Unvested, weighted average award date value, ending balance | $ 23.98 | $ 21.14 | |
Weighted average remaining contractual life (years) | 2 years 3 months 18 days | | |
Unrecognized compensation cost | $ | $ 1,909 | | |
Aggregate intrinsic value, unvested | $ | $ 4,472 | | |
Employee PRSUs [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, ending balance | shares | 121,435 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, ending balance | $ 23.75 | | |
Weighted average remaining contractual life (years) | 2 years 7 months 6 days | | |
Unrecognized compensation cost | $ | $ 1,662 | | |
Aggregate intrinsic value, unvested | $ | $ 3,825 | | |
Nonemployee Director PRSUs [Member] | | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | | | |
Unvested, ending balance | shares | 20,550 | | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | | | |
Unvested, weighted average award date value, ending balance | $ 25.32 | | |
Weighted average remaining contractual life (years) | 1 year 3 months 18 days | | |
Unrecognized compensation cost | $ | $ 247 | | |
Aggregate intrinsic value, unvested | $ | $ 647 | | |